We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · May 13, 2015

LY2963016 Insulin Glargine Is Similar to Insulin Glargine for Treatment of T2D

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Similar Efficacy and Safety of LY2963016 Insulin Glargine and Insulin Glargine (Lantus®) in Patients With Type 2 Diabetes Previously Treated With Insulin Glargine or Insulin-Naïve: A Randomised, Double-Blind Controlled Trial (The ELEMENT 2 Study)
Diabetes Obes Metab 2015 Apr 30;[EPub Ahead of Print], J Rosenstock, P Hollander, A Bhargava, LL Ilag, RK Pollom, JS Zielonka, WJ Huster, MJ Prince

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading